Summary
A total of 7 patients (3–21 years old) suffering from an intractable “primary” Lennox-Gastaut syndrome (LGS) were treated with i.v. high doses of polyvalent human immunoglobulins. Of these patients 6 improved following such treatment with a decrease in fits and an improvement in the EEG.
Hypotheses about the contribution of the treatment and immunopathological factors in some cases of idiopathic LGS are discussed.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aarli JA, Fontana A (1980) Immunological aspects of epilepsy. Epilepsia 21:451–457
Aicardi J (1982) Childhood epilepsies with brief myoclonic, atonic or tonic seizures. Textbook of epilepsy. In: Laidlaw J, Richens A (eds) 2nd ed. Churchill Livingstone, London, pp 88–96
Ariizumi M, Shiihara H, Hibio S, Ryos S, Baba K, Ogawa K, Suzuki Y, Momoki T (1983) High dose gammaglobulin for intractable childhood epilepsy. Lancet II: 162–163
Bassanini M, Baez A, Sotelo J (1982) Immunoglobulins in epilepsy. J Neurol Sci 56:275–281
Delire M, Petit B, Fiasse L, Masson PL (1980) The therapeutic efficacy of human immunoglobulins as a function of their in vitro antibody activity toward circulating antigens in children with recurrent infections of the upper respiratory tract. J Clin Lab Immunol 4:159–163
Fontana A, Fulpius BW, Cuénod S (1978) Antikörper gegen nicotinartige Acetylcholinrezeptoren des Zentralnervensystems und der Muskulatur bei Epileptikern mit IgA-Mangel. Schweiz Med Wochenschr 108:1307–1310
Gilhus NE, Aarli JA (1981) Immunoglobulin concentrations in patients with a history of febrile convulsions prior to the development of epilepsy. Neuropediatrics 12:314–318
Gilhus NE, Aarli JA, Thorsby E (1982) HLA antigens in epileptic patients with drug-induced immunodeficiency. Int J Immunopharmacol 4:517–520
Gronski P, Hofstaetter T, Kanzy EJ, Lüben G, Seiler FR (1983) S-Sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. Vox Sang 45: 144–196
Hoffmann MK, Kappler JW (1978) Two distinct mechanisms of immune suppression by antibody. Nature 272:64–65
Hoshino C, Yotsumiya N, Yata J (1982) Relationship between anti-GMI antibody and CNS destructions in nervous diseases. Acta Pediatr Jpn 86:1694
Newland AC, Treleaven JG, Minchinton RM, Waters AH (1983) High dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet I 84–87
Seager J, Wilson J, Jamieson DL, Hayward AR, Soothill JF (1975) IgA deficiency, epilepsy and phenytoin treatment. Lancet II:632–635
Shakir RA, Behan PO, Dick H, Lambie DG (1978) Metabolism of immunoglobulin A, lymphocyte function and histocompatibility antigens in patients on anticonvulsants. J Neurol Neurosurg Psychiatry 41:307–311
Smeraldi E, Scorza-Smeraldi R, Cazzullo CL, Guareschi Cazzullo A, Fabio G, Canger R (1975) Immunogenetics of the Lennox-Gastaut Syndrome: Frequency of HLA antigens and haplotypes in patients and first degree relatives. Epilepsia 16:699–703
Smeraldi E, Scorza-Smeraldi R, Guareschi-Cazzullo A, Cazzullo CL, Rugarli C, Canger R (1978) Immunogenetics of Lennox-Gastaut Syndrome: Search for LD determinants as genetic markers of the syndrome. Boll-Ist-Sieroter, Milan 56:544–551
Stockinger B, Lemmel EM (1978) Fc receptor dependency of antibody mediated feedback regulation: on the mechanisms of inhibition. Cell Immunol 40:395–403
Tartara A, Verri AP, Nespoli L, Moglia A, Botta MG (1981) Immunological findings in epileptic and febrile convulsion patients before and under treatment. Eur Neurol 20: 306–311
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Rijckevorsel-Harmant, K., Delire, M. & Rucquoy-Ponsar, M. Treatment of idiopathic west and lennox-gastaut syndromes by intravenous administration of human polyvalent immunoglobulins. Eur Arch Psychiatr Neurol Sci 236, 119–122 (1986). https://doi.org/10.1007/BF00454021
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00454021